Omeprazole and Midostaurin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Omeprazole (omeprazole) and Midostaurin (midostaurin). Common drug interactions include lung infiltration among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Omeprazole and Midostaurin. It is created by eHealthMe based on reports of 34 people who take the same drugs from the FDA, and is updated regularly.

What is Omeprazole?

Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.

What is Midostaurin?

Midostaurin has active ingredients of midostaurin. eHealthMe is studying from 1,137 Midostaurin users. Check the latest studies of Midostaurin.



On Jul, 07, 2026

34 people who take Omeprazole and Midostaurin together, and have interactions are studied.

Omeprazole and Midostaurin drug interactions.

What are the common drug interactions of Omeprazole and Midostaurin, by gender? *:

female:

  1. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  2. Sepsis (a severe blood infection that can lead to organ failure and death)
  3. Septic shock (shock due to blood infection)
  4. Anal abscess
  5. Pneumonia
  6. Cholecystitis (infection of gallbladder)
  7. Anaemia (lack of blood)
  8. Asthenia (weakness)
  9. Bone marrow disorder
  10. Cardiac failure

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Diarrhoea
  3. Systemic mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body)
  4. Ascites (accumulation of fluid in the abdominal cavity)
  5. Asthenia (weakness)
  6. Back pain
  7. Lethargy (tiredness)
  8. Nausea (feeling of having an urge to vomit)
  9. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  10. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

What are the common drug interactions of Omeprazole and Midostaurin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Thrombocytopenia (decrease of platelets in blood)

20-29:

n/a

30-39:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Septic shock (shock due to blood infection)

40-49:

  1. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  2. Pneumonia
  3. Pulmonary hypertension (increase in blood pressure in the lung artery)
  4. Anaemia (lack of blood)
  5. Cardiac failure
  6. Ejection fraction decreased (systolic heart failure)
  7. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  8. Hypersplenism (enlarged spleen and a decrease in one or more types of blood cells)
  9. Malignant neoplasm progression (cancer tumour came back)
  10. Nausea (feeling of having an urge to vomit)

50-59:

n/a

60+:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Diarrhoea
  3. Systemic mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body)
  4. Anal abscess
  5. Ascites (accumulation of fluid in the abdominal cavity)
  6. Asthenia (weakness)
  7. Back pain
  8. Lethargy (tiredness)
  9. Nausea (feeling of having an urge to vomit)
  10. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 19 people, 55.88%
  2. Febrile Neutropenia (fever with reduced white blood cells): 8 people, 23.53%
  3. Systemic Mastocytosis (a condition caused by the accumulation of mast cells in more than one part of the body): 7 people, 20.59%
  4. Indigestion: 5 people, 14.71%
  5. Arrhythmias (irregular heartbeat): 5 people, 14.71%
  6. Blood Albumin Decreased: 5 people, 14.71%
  7. High Blood Pressure: 5 people, 14.71%
  8. Abdominal Distension: 5 people, 14.71%
  9. Proctitis (inflammation of the rectum and anus): 5 people, 14.71%
  10. Fever: 4 people, 11.76%

* Approximation only. Some reports may have incomplete information.

Do you take Omeprazole and Midostaurin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Omeprazole and Midostaurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Omeprazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Midostaurin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omeprazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midostaurin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on omeprazole and midostaurin (the active ingredients of Omeprazole and Midostaurin, respectively), and Omeprazole and Midostaurin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: